Stock markets in Asia closed Tuesday with gains as fears about the omicron variant of coronavirus eased.
The US pharmaceutical and biotechnology company Moderna announced Monday that the vaccine developed against COVID-19 produces a strong antibody response against the omicron.
The Japanese parliament's enactment of an additional 36 trillion yen ($316.5 billion) budget for the fiscal year 2021 also supported the rise in the stock markets.
The Asia Dow, which includes the region's blue-chip companies, jumped 43.56 points, or 1.19%, to close at around 3,715 points.
The Nikkei 225 index in Tokyo gained 579.78 points, or 2.08%, to hit 28,517.
The Hang Seng, the benchmark for blue-chip stocks trading on the Hong Kong stock exchange, climbed 226.47 points, or 1%, to 22,971.
China’s Shanghai stock exchange rose 31.52 points, or 0.88%, to 3,625, while the Indian Sensex benchmark gained 296.48 points, or 0.53%, to close at 56,118 points.
The Singapore index also increased 12.21 points, or 0.40%, to 3,085.